top of page

Valproate, Pregnancy & Folic Acid — PLAB 2 High-Yield Guide


If you see a woman planning pregnancy while on Sodium valproate, this is a classic PLAB 2 station. The examiner is testing your ability to recognise risk, counsel clearly, and involve the right team.

This blog gives you a structured, exam-ready approach.


Why is Valproate a Problem?

Sodium valproate is highly teratogenic, meaning it can harm the baby, especially in early pregnancy.


Key risks:

  • Neural tube defects (e.g., spina bifida)

  • Developmental problems (low IQ, autism, learning difficulties)

  • Fetal valproate syndrome (facial features, heart defects)

📌 Important:

  • Damage occurs very early (first 4 weeks)

  • Often before pregnancy is detected

  • Risk increases with higher doses

👉 This is why valproate must be avoided in women planning pregnancy


What Examination Should You Do?

In PLAB 2, “examination” = focused pre-conception assessment

1. General Examination

  • Vitals (BP, BMI)

  • Look for obesity or endocrine features (e.g., PCOS)

2. Neurological Examination

  • Baseline neurological status

  • Any focal deficits

3. Pre-conception Assessment

  • Menstrual history clues (hormonal imbalance)

  • No internal exam unless indicated



Key Investigations (Don’t Miss These)

  • LFTs → hepatotoxicity risk

  • FBC → thrombocytopenia

  • Blood glucose / HbA1c

  • Pregnancy test (baseline)



What Should You Do About the Medication?

👉 Do NOT stop valproate abruptly

Who changes the medication?

  • Neurologist (epilepsy)

  • Psychiatrist (bipolar disorder)

Safer alternatives:

  • Lamotrigine (first-line)

  • Levetiracetam


Pregnancy Prevention Programme (PPP) — VERY HIGH-YIELD

The Pregnancy Prevention Programme (PPP) is a strict safety system created by the Medicines and Healthcare products Regulatory Agency to prevent pregnancy in patients taking Sodium valproate.


👉 Why? Because valproate has a very high risk of causing serious harm to the baby.


PPP applies to:

👉 All females of childbearing potential, including:

  • Women planning pregnancy

  • Women not planning pregnancy but capable of becoming pregnant

  • Adolescent girls approaching puberty

❗ Important:

  • It applies even if they are not currently sexually active

  • Because risk can arise if pregnancy occurs unexpectedly


PPP is a shared responsibility:

Specialist (Neurologist / Psychiatrist)

  • Decides if valproate is absolutely necessary

  • Reviews patient at least once a year

  • Completes risk acknowledgement form


Key points:

  • Valproate should only be used if no safer alternative exists

  • Effective contraception is mandatory

  • Requires annual specialist review and risk acknowledgement

  • Patients must understand the risks to the baby

👉 Simple rule: No contraception = No valproate



Folic Acid — The MOST Tested Part


When to start?

  • Ideally 3 months before conception

  • Continue until 12 weeks of pregnancy


Dose Guide

Situation

Dose

Low risk

400 micrograms daily

High risk

5 mg daily



Who Needs HIGH-DOSE (5 mg)?


1. Previous neural tube defect

  • Personal or previous baby affected

2. On high-risk medications

  • Sodium valproate

  • Carbamazepine

  • Methotrexate

3. Diabetes

  • Type 1 or Type 2

4. Obesity

  • BMI ≥ 30

5. Haemoglobinopathies

  • Sickle cell disease, thalassemia

6. Malabsorption

  • Coeliac disease, post-bariatric surgery

7. Family history of NTD


Important Clarification (Exam Favourite)

👉 Even after switching from valproate to a safer drug like Lamotrigine:

✔️ Still give folic acid (5 mg)

  • Because:

    • Antiepileptics can affect folate metabolism

    • All women planning pregnancy benefit



Contraception Advice (CRUCIAL)

  • Use effective contraception until:

    • Medication is safely changed

    • Condition is stable



Referral & Follow-up

  • Refer to:

    • Neurologist / Psychiatrist

    • High-risk antenatal clinic

  • Ensure:

    • Good seizure/condition control before pregnancy


Driving Advice (Often Tested with Epilepsy)

Driving rules are set by the Driver and Vehicle Licensing Agency (DVLA).


Key points:

  • Must stop driving after a seizure

  • Can resume only after:

    • 12 months seizure-free (most cases)

  • Must inform DVLA

👉 Important:

  • Medication changes may increase seizure risk → temporary driving restriction



PLAB 2 PERFECT STRUCTURE (30–40 sec answer)

👉 “This medication is unsafe in pregnancy due to risk of birth defects. I would advise not stopping it suddenly, start high-dose folic acid, and ensure effective contraception. I would refer her to a specialist to switch to a safer alternative like lamotrigine before planning pregnancy.”



Common Examiner Traps

❌ Stopping valproate immediately

❌ Not mentioning folic acid

❌ Not advising contraception

❌ Not involving a specialist


Communication Skills:


  • Use simple, clear explanations (avoid jargon)

  • Explain risk without causing panic

  • Avoid rehearsed phrases; be natural and empathetic

  • Structure consultation logically:

    • Explain risk → plan → reassurance

  • Check understanding and involve patient in decisions

  • Avoid overusing phrases like “Is that okay?” or sounding scripted



Final Takeaway

  • Recognise risk early

  • Do NOT stop abruptly

  • Start folic acid (5 mg)

  • Refer for specialist-led switch

  • Ensure safe pregnancy planning


📚 References


Comments

bottom of page